![David Radford](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
David Radford
Vorstandsvorsitzender bei ANTEOTECH LIMITED
Vermögen: 25 602 $ am 31.05.2024
Profil
David John Radford is currently the Chief Executive Officer, MD & Executive Director at AnteoTech Ltd.
He previously worked as the Chief Executive Officer & Executive Director at Nanosonics Ltd.
and as the Chief Executive Officer, Director & MD at Hunter Immunology Pty Ltd.
He also served as the Chief Executive Officer, Executive Director & MD at Bioxyne Ltd.
and as the Chief Executive Officer at Epsilon Healthcare Ltd.
Additionally, he was the Chief Executive Officer at Allvascular Holdings Pty Ltd.
Radford obtained an undergraduate degree from the University of the West of England and an MBA from the Australian Graduate School of Management.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
ANTEOTECH LTD
0,06% | 14.11.2023 | 1 604 166 ( 0,06% ) | 25 602 $ | 31.05.2024 |
Aktive Positionen von David Radford
Unternehmen | Position | Beginn |
---|---|---|
ANTEOTECH LIMITED | Vorstandsvorsitzender | 04.10.2022 |
Ehemalige bekannte Positionen von David Radford
Unternehmen | Position | Ende |
---|---|---|
EPSILON HEALTHCARE LIMITED | Vorstandsvorsitzender | 11.07.2018 |
BIOXYNE LIMITED | Präsident | 12.12.2012 |
NANOSONICS LIMITED | Vorstandsvorsitzender | 16.05.2011 |
Allvascular Holdings Pty Ltd. | Vorstandsvorsitzender | - |
Hunter Immunology Pty Ltd.
![]() Hunter Immunology Pty Ltd. Medical SpecialtiesHealth Technology Hunter Immunology Ltd. operates as a biotechnology company. It develops immune modulators for treatment of respiratory diseases. The company was founded by Phillip Comans in 2003 and is headquartered in Victoria, Australia. | Vorstandsvorsitzender | - |
Ausbildung von David Radford
University of the West of England | Undergraduate Degree |
Australian Graduate School of Management | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 4 |
---|---|
NANOSONICS LIMITED | Health Technology |
ANTEOTECH LIMITED | Health Technology |
BIOXYNE LIMITED | Commercial Services |
EPSILON HEALTHCARE LIMITED | Health Technology |
Private Unternehmen | 2 |
---|---|
Hunter Immunology Pty Ltd.
![]() Hunter Immunology Pty Ltd. Medical SpecialtiesHealth Technology Hunter Immunology Ltd. operates as a biotechnology company. It develops immune modulators for treatment of respiratory diseases. The company was founded by Phillip Comans in 2003 and is headquartered in Victoria, Australia. | Health Technology |
Allvascular Holdings Pty Ltd. |